Arthrosamid® is a next-generation injectable treatment for knee osteoarthritis, designed to offer long-lasting pain relief and improved joint function. It’s especially beneficial for individuals who haven’t responded well to conventional treatments such as steroid injections, physiotherapy, or oral medications.
The procedure involves a single injection of a hydrogel made up of 97.5% water and 2.5% cross-linked polyacrylamide. Once injected into the knee joint, Arthrosamid® cushions the joint and integrates with the synovial membrane - the soft tissue lining the joint capsule. This helps reduce inflammation, stiffness, and pain, while enhancing mobility.
Unlike traditional visco-supplement injections, Arthrosamid® becomes part of the joint lining, offering sustained relief that can last up to three years or more.
It’s particularly effective for advanced osteoarthritis, including cases where cartilage has significantly worn down - commonly referred to as “bone-on-bone” arthritis.